Coronapod: solving the COVID vaccine manufacturing problem
Listen now
Less than 1% of those in low income countries are fully vaccinated, and that number only rises to 10% in low-middle income countries. Meanwhile more than half of the population in wealthier countries have received a double dose with several now rolling out third dosess. In this episode of Coronapod we look at the role of pharmaceutical manufacturers. Drug companies are facing increased pressure to partner with manufacturing firms in the global south but most are reluctant to relinquish control. We ask what needs to change to help address the global disparity in vaccine access. News: The fight to manufacture COVID vaccines in lower-income countries   See for privacy and opt-out information.
More Episodes
The unexpected origins of a 4000-year-old people, protecting your ‘digital presence’ and what to expect from COP26.   See for privacy and opt-out information.
Published 10/27/21
People that have recovered from COVID are seeing stronger immune responses after vaccination than those that never contracted the virus. Researchers are now racing to unpick what is behind this powerful 'hybrid immunity'. In this episode of Coronapod, we discuss a series of studies which are...
Published 10/25/21
An ancient solar storm helps pinpoint when Vikings lived in the Americas, and using magnets to deftly move non-magnetic metals.   See for privacy and opt-out information.
Published 10/20/21